The global single-cell analysis market is expected to grow at a CAGR of 13.9% from 2024 to 2034, driven by the increasing demand for precision medicine and cancer research. Single-cell analysis is essential for understanding complex biological processes at the cellular level, allowing for early diagnosis of diseases and personalized treatment strategies.